Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A subunit vaccine for multiple respiratory viruses.

Science advances·2026
Same author

Quillaja saponaria fraction QS-18 as an adjuvant for liposomal seasonal influenza vaccines.

NPJ vaccines·2026
Same author

Ganglioside enhances the immunogenicity of nanoparticles displaying short synthetic tumor neoepitopes and epitopes.

Theranostics·2026
Same author

Role of the anti-Shine-Dalgarno sequence of 16S rRNA in Flavobacterium johnsoniae.

Nucleic acids research·2026
Same author

Structure of a specialized 70S initiation complex.

Nucleic acids research·2026
Same author

Self-assembling freeze-dried vaccine for short HLA-A2-restricted melanoma peptide epitopes.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: Jul 12, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

['Same-day' thyroid surgery. Results after 805 thyroidectomies in a fast-track program].

Joaquín Ortega1, Norberto Cassinello, Salvador Lledó

  • 1Unidad de Cirugía Endocrina y de la Obesidad, Servicio de Cirugía General y del Aparato Digestivo, Hospital Clínico Universitario, Blasco Ibáñez 17, 46010 Valencia, Spain. joaquin.ortega@uv.es

Cirugia Espanola
|September 6, 2007
PubMed
Summary

Fast-track surgery for thyroid disease, with less than 24-hour admission, is safe and effective. This approach is suitable for most thyroid surgeries within specialized endocrine surgery units.

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Related Experiment Videos

Last Updated: Jul 12, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Area of Science:

  • Endocrine Surgery
  • Surgical Outcomes
  • Patient Management

Context:

  • Thyroid disease management often involves extended hospital stays.
  • Fast-track surgery programs aim to reduce admission duration.
  • Evaluating the efficacy of short-stay protocols is crucial for optimizing healthcare resources.

Purpose:

  • To assess the validity and safety of a fast-track surgery program for thyroid disease.
  • To analyze outcomes including morbidity, reinterventions, and readmissions for patients with <24-hour admission.
  • To determine which thyroid procedures are suitable for this expedited approach.

Summary:

  • A 6-year study of 805 patients undergoing thyroid surgery in a fast-track program (<24-hour admission) was conducted.
  • Low rates of complications (hypocalcemia, dysphonia) were observed, with few emergency reinterventions (hemorrhage).
  • Most patients were discharged within 24 hours, demonstrating the feasibility of the fast-track model for various thyroid procedures.

Impact:

  • Fast-track surgery is validated for most thyroidectomies, excluding those with cancer requiring neck dissection.
  • This model can improve hospital efficiency and patient throughput in endocrine surgery.
  • Optimized patient selection can enhance the success of short-stay thyroid surgery programs.